{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:07:25Z","timestamp":1794049645304,"version":"4.8.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017413","name":"Innovation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1195709"],"award-info":[{"award-number":["APP1195709"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.neurobiolaging.2026.04.003","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:27:10Z","timestamp":1776284830000},"page":"79-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Combining cannabidiol and delta-9-tetrahydrocannabinol at a 50:3 ratio \u2013 a new therapeutic strategy for APPSwe\/PS1\u0394E9 transgenic mice?"],"prefix":"10.1016","volume":"164","author":[{"given":"Madilyn","family":"Coles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Rosa Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Chesworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve Z.","family":"Steiner-Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9904-8482","authenticated-orcid":false,"given":"Tim","family":"Karl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neurobiolaging.2026.04.003_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drudis.2016.08.005","article-title":"Targeting the endocannabinoid system: future therapeutic strategies","volume":"22","author":"Aizpurua-Olaizola","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2026.04.003_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/1533317506292282","article-title":"Sensory gating in patients with Alzheimer\u2019s disease and their biological children","volume":"21","author":"Ally","year":"2007","journal-title":"Am. J. Alzheimer's. Dis. & Other Dement. \u00ae"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2026.04.003_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/alz.12328","article-title":"2021 Alzheimer's disease facts and figures","volume":"17","author":"Alzheimer\u2019s Association","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2026.04.003_bib4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3233\/JAD-141014","article-title":"Cannabis-based medicine reduces multiple pathological processes in A\u03b2PP\/PS1 mice","volume":"43","author":"Aso","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2026.04.003_bib5","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3233\/JAD-160533","article-title":"Delineating the efficacy of a cannabis-based medicine at advanced stages of dementia in a murine model","volume":"54","author":"Aso","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2026.04.003_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3233\/JAD-150913","article-title":"Cannabinoid receptor 2 participates in amyloid-\u03b2 processing in a mouse model of Alzheimer\u2019s disease but plays a minor role in the therapeutic properties of a cannabis-based medicine","volume":"51","author":"Aso","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2026.04.003_bib7","first-page":"1008","article-title":"Deficit in sensorimotor gating in Alzheimer's disease (AD): measuring prepulse inhibition (PPI) as a measure of liabilty to AD","volume":"2","author":"Aziz","year":"2019","journal-title":"Ann. Psychiatr. Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2026.04.003_bib8","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nm.4311","article-title":"A chronic low dose of \u0394 9-tetrahydrocannabinol (THC) restores cognitive function in old mice","volume":"23","author":"Bilkei-Gorzo","year":"2017","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2026.04.003_bib9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0896-6273(00)80974-5","article-title":"Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins","volume":"19","author":"Borchelt","year":"1997","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2026.04.003_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.wnp.0000218991.99714.ee","article-title":"Sensory gating deficit assessed by P50\/Pb middle latency event related potential in Alzheimer\u2019s disease","volume":"23","author":"Cancelli","year":"2006","journal-title":"J. Clin. Neurophysiol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2026.04.003_bib11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-130050","article-title":"Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy","volume":"35","author":"Casarejos","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbr.2013.02.008","article-title":"Novel behavioural characteristics of the APPSwe\/PS1\u0394E9 transgenic mouse model of Alzheimer's disease","volume":"245","author":"Cheng","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbr.2013.11.046","article-title":"Novel behavioural characteristics of female APPSwe\/PS1\u0394E9 double transgenic mice","volume":"260","author":"Cheng","year":"2014","journal-title":"Behav. Brain Res."},{"issue":"15","key":"10.1016\/j.neurobiolaging.2026.04.003_bib14","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","article-title":"Chronic cannabidiol treatment improves social and object recognition in double transgenic APP(Swe)\/PS1\u0394E9 mice","volume":"231","author":"Cheng","year":"2014","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2026.04.003_bib15","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3233\/JAD-140921","article-title":"Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice","volume":"42","author":"Cheng","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.931384","article-title":"Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer's disease mouse model","volume":"13","author":"Chesworth","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.587604","article-title":"Medium-dose chronic cannabidiol treatment reverses object recognition memory deficits of APP Swe\/PS1\u0394E9 transgenic female mice","volume":"11","author":"Coles","year":"2020","journal-title":"Front. Pharm."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.962922","article-title":"Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer\u2019s disease","volume":"16","author":"Coles","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drugalcdep.2013.12.013","article-title":"Investigation of sex-dependent effects of cannabis in daily cannabis smokers","volume":"136","author":"Cooper","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2026.04.003_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2007.09.004","article-title":"Gonadal hormone modulation of the behavioral effects of \u03949-tetrahydrocannabinol in male and female rats","volume":"578","author":"Craft","year":"2008","journal-title":"Eur. J. Pharm."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2026.04.003_bib21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/jpet.111.188540","article-title":"Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat","volume":"340","author":"Craft","year":"2012","journal-title":"J. Pharm. Exp. Ther."},{"issue":"8-9","key":"10.1016\/j.neurobiolaging.2026.04.003_bib22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.lfs.2012.06.009","article-title":"Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?","volume":"92","author":"Craft","year":"2013","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2026.04.003_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neubiorev.2007.01.005","article-title":"The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents","volume":"31","author":"Dere","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2026.04.003_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0166-4328(02)00294-2","article-title":"Partial reinforcement across trials impairs escape performance but spares place learning in the water maze","volume":"141","author":"Devan","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.beproc.2016.09.009","article-title":"Sex differences on the competitive place task in the water maze: the influence of peripheral pool time on spatial navigation performance in rats","volume":"132","author":"Devan","year":"2016","journal-title":"Behav. Process."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2026.04.003_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00109-005-0025-1","article-title":"The marijuana component cannabidiol inhibits \u03b2-amyloid-induced tau protein hyperphosphorylation through Wnt\/\u03b2-catenin pathway rescue in PC12 cells","volume":"84","author":"Esposito","year":"2006","journal-title":"J. Mol. Med."},{"issue":"12","key":"10.1016\/j.neurobiolaging.2026.04.003_bib27","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1177\/02698811221125440","article-title":"Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze","volume":"36","author":"Fabris","year":"2022","journal-title":"J. Psychopharm."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108648","article-title":"Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles","volume":"221","author":"Fedorova","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pbb.2016.01.007","article-title":"Sex differences in the subjective effects of oral \u03949-THC in cannabis users","volume":"152","author":"Fogel","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib30","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.neubiorev.2019.09.036","article-title":"How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review","volume":"107","author":"Freeman","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib31","series-title":"Characterization Using Behavioral Tests","first-page":"1","article-title":"The open field test","author":"Gould","year":"2009"},{"issue":"111984","key":"10.1016\/j.neurobiolaging.2026.04.003_bib32","first-page":"1","article-title":"Sex-specific spatial memory deficits in mice with a conditional TrkB deletion on parvalbumin interneurons","volume":"372","author":"Grech","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fnagi.2018.00437","article-title":"Executive functions in Alzheimer disease: a systematic review","volume":"10","author":"Guarino","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"12","key":"10.1016\/j.neurobiolaging.2026.04.003_bib34","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.euroneuro.2017.10.037","article-title":"Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC","volume":"27","author":"Hlo\u017eek","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2026.04.003_bib35","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.neurobiolaging.2003.09.008","article-title":"APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1","volume":"25","author":"Jankowsky","year":"2004","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2026.04.003_bib36","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1176\/appi.ajp.158.8.1319","article-title":"Sensory gating deficit expressed by a disturbed suppression of the P50 event-related potential in patients with Alzheimer\u2019s disease","volume":"158","author":"Jessen","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2026.04.003_bib37","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbr.2011.04.051","article-title":"Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit?","volume":"223","author":"Karl","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2026.04.003_bib38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00213-011-2342-0","article-title":"Cannabidiol potentiates \u0394 9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats","volume":"218","author":"Klein","year":"2011","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2026.04.003_bib39","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12213","article-title":"Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019","volume":"17","author":"Knopman","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib40","first-page":"1","article-title":"Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1G93A) mouse model of amyotrophic lateral sclerosis include sex-dependent phenotypes. Genes","volume":"e12604","author":"Kreilaus","year":"2019","journal-title":"Brain Behav."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.113812","article-title":"Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58\/2 transgenic mice","volume":"425","author":"Kreilaus","year":"2022","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2026.04.003_bib42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neulet.2004.07.069","article-title":"Exploratory activity, anxiety, and motor coordination in bigenic APPswe+ PS1\/\u0394E9 mice","volume":"369","author":"Lalonde","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2026.04.003_bib43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5498\/wjp.v6.i1.54","article-title":"Sex differences in cognitive impairment in Alzheimer\u2019s disease","volume":"6","author":"Laws","year":"2016","journal-title":"World J. Psychiatry"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2026.04.003_bib44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/ijms18010026","article-title":"Cannabidiol modulates the expression of Alzheimer\u2019s disease-related genes in mesenchymal stem cells","volume":"18","author":"Libro","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2026.04.003_bib45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2026.04.003_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbr.2010.01.020","article-title":"Evaluating spatial memory function in mice: a within-subjects comparison between the water maze test and its adaptation to dry land","volume":"209","author":"Llano Lopez","year":"2010","journal-title":"Behav. Brain Res."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2026.04.003_bib47","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1017\/S1461145709990605","article-title":"A behavioural comparison of acute and chronic \u03949-tetrahydrocannabinol and cannabidiol in C57BL\/6JArc mice","volume":"13","author":"Long","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2026.04.003_bib48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1601-1848.2004.00076.x","article-title":"Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice","volume":"3","author":"Moy","year":"2004","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.718850","article-title":"Efficacy of \u03949-tetrahydrocannabinol (THC) alone or in combination with a 1:1 ratio of cannabidiol (CBD) in reversing the spatial Llearning deficits in old mice","volume":"13","author":"Nidadavolu","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2026.04.003_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165144","article-title":"Behavioural phenotyping of APPswe\/PS1\u03b4E9 mice: age-rrelated changes and effect of long-term paroxetine treatment","volume":"11","author":"Olesen","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2026.04.003_bib51","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00401-018-1920-1","article-title":"Sex differences in Alzheimer\u2019s disease and common neuropathologies of aging","volume":"136","author":"Oveisgharan","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2026.04.003_bib52","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/brain\/awad005","article-title":"Anti-amyloid antibody therapies in Alzheimer\u2019s disease","volume":"146","author":"Perneczky","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2026.04.003_bib53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/jnnp.2003.035022","article-title":"Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson\u2019s disease dementia and Alzheimer\u2019s disease","volume":"76","author":"Perriol","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib54","article-title":"Female wild-type and APP\/PS1 transgenic mice deficient in Sort1 are prone to anxiety-like behavior at older ages","author":"Ruan","year":"2017","journal-title":"Neuropsychiatry (Lond. ) 7(6) 1047-1052"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2026.04.003_bib55","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neurobiolaging.2017.09.025","article-title":"Reversal of age-related cognitive impairments in mice by an extremely low dose of tetrahydrocannabinol","volume":"61","author":"Sarne","year":"2018","journal-title":"Neurobiol. Aging"},{"issue":"94","key":"10.1016\/j.neurobiolaging.2026.04.003_bib57","first-page":"1","article-title":"Prolonged cannabidiol treatment lacks on detrimental effects on memory, motor performance and anxiety in C57BL\/6J mice","volume":"13","author":"Schleicher","year":"2019","journal-title":"Front. Behav. Neurosci."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2026.04.003_bib58","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1007\/s12035-019-1637-8","article-title":"Efficacy of cannabinoids in a pre-clinical drug-screening platform for Alzheimer\u2019s disease","volume":"56","author":"Schubert","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2026.04.003_bib59","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ptr.5095","article-title":"Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement","volume":"28","author":"Scuderi","year":"2014","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2026.04.003_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02518-2","article-title":"Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties","volume":"18","author":"Sharpe","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2018.01.014","article-title":"Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol","volume":"139","author":"da Silva","year":"2018","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2026.04.003_bib62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bbr.2008.12.034","article-title":"Intermediate-and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition","volume":"200","author":"Taglialatela","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"8","key":"10.1016\/j.neurobiolaging.2026.04.003_bib63","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.euroneuro.2014.04.003","article-title":"Repeated but not acute treatment with\u2206 9-tetrahydrocannabinol disrupts prepulse inhibition of the acoustic startle: reversal by the dopamine D2\/3 receptor antagonist haloperidol","volume":"24","author":"Tournier","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2026.04.003_bib64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1440-1819.2006.01460.x","article-title":"Prepulse inhibition of acoustic startle response in mild cognitive impairment and mild dementia of Alzheimer type","volume":"60","author":"Ueki","year":"2006","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.1010478","article-title":"The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia","volume":"16","author":"Visini","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib66","first-page":"89","article-title":"Neural correlates of spatial navigation changes in mild cognitive impairment and Alzheimer\u2019s disease","volume":"8","author":"Vl\u010dek","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2026.04.003_bib67","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bbr.2012.05.007","article-title":"Sensorimotor gating and memory deficits in an APP\/PS1 double transgenic mouse model of Alzheimer's disease","volume":"233","author":"Wang","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2026.04.003_bib68","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3233\/JAD-191242","article-title":"Chronic treatment with 50 mg\/kg cannabidiol improves cognition and moderately reduces A\u03b2 40 levels in 12-month-old Male A\u03b2PP swe\/PS1\u0394E9 transgenic mice","volume":"74","author":"Watt","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172970","article-title":"Chronic cannabidiol (CBD) treatment did not exhibit beneficial effects in 4-month-old male TAU58\/2 transgenic mice","volume":"196","author":"Watt","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2026.04.003_bib70","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s40266-016-0372-3","article-title":"Pharmacotherapy for dementia: a practical approach to the use of cholinesterase inhibitors and memantine","volume":"33","author":"Wong","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.neurobiolaging.2026.04.003_bib71","unstructured":"World Health Organisation, 2023. Dementia. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia. (Accessed April 2023)."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458026000606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458026000606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:50:24Z","timestamp":1778925024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458026000606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":71,"alternative-id":["S0197458026000606"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.04.003","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining cannabidiol and delta-9-tetrahydrocannabinol at a 50:3 ratio \u2013 a new therapeutic strategy for APPSwe\/PS1\u0394E9 transgenic mice?","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}